Best Reviewer of Issue January-February 2020  - Hooman Djaladat
Hooman Djaladat

February 2020

Hooman Djaladat, M.D., M.S., is an associate professor 
of clinical urology at the USC Institute of Urology 
since 2012. He earned his medical degree from Tehran 
University of Medical Sciences and graduated from 
medical school as top 1%. He completed his residency 
training in Sina hospital, Tehran, Iran. Before finishing 
his residency, he participated in an endourology and 
oncology course in Medway Maritime NHS Trust center 
affiliated to the University College of London. Being 
among the top scorers of the Iranian Urology Board 
Exam (2004), he was appointed as an assistant professor 
of urology at Hormozgan University of Medical Sciences 

from 2004 to 2007. To continue his scientific endeavor, he took part in an endourology and 
laparoscopy clinical fellowship program at Labbafinejad Medical Center which is one of the 
most prestigious centers pioneering modern urology in the Middle East. Subsequently he moved 
to the USA were he performed research in the field of urologic oncology at the Norris Cancer 
Center. He then pursued a SUO-accredited urologic oncology fellowship at the Keck School of 
Medicine of USC in 2012 and a complimentary course in robotic surgery, and then immediately 
joined the USC Institute of Urology as faculty member. Dr. Djalalat also accomplished a 
master degree in clinical, biomedical, and translational investigation at the Preventive Medicine 
department of USC in 2014. 
He specializes in complex endourology and oncology cases (caval thrombus, retroperitoneal 
sarcoma, salvage cystectomy) and also minimally invasive/robotic techniques with more than 
18 years of experience in this field. He is a member of many scientific societies such as the 
European Association of Urology, Society of Urologic Oncology, Western Section American 
Urologic Association, and American Urologic Association. Dr. Djaladat is very passionate 
about research, mainly focusing on clinical and translational studies in bladder, testis, and 
kidney cancer. He has presented over 160 abstracts at scientific meetings, published more 
than 90 peer-reviewed articles and book chapters, and has invented a new Foley catheter for 
prostatectomy patients, which has been filed with the US Patent and Trade Organization. He is 
currently the PI of a novel RCT studying “Biologic Mesh in Preventing Hernia in Patients with 
Bladder Cancer Undergoing Radical Cystectomy with Ileal Conduit Diversion”. Dr. Djaladat is 
a reviewer for many journals in the field of urology. He has been selected by the editorial board 
of the “Urology Journal” as the best reviewer of January-February 2020 issue.